With collaboration with UMC Utrecht, we are currently working on adding on our product portfolio NGSgo-ONCOdentify, hemato-oncology diagnostic assays that focus on several leukemia types. The first kit that we are working on will include molecular markers for Myeloproliferative Neoplasms (MPN). This class of neoplasms includes the subtypes CML, PV, ET and PMF.
The NGSgo-ONCOdentifier MPN kit will include the genetic markers JAK2, CALR and MPL. Knowing the presence of mutations on those genes is valuable for predicting prognosis and selecting treatment options.
